R&D Systems/TECHNE Corporation
Our significant investor TECHNE Corporation, through their R&D Systems subsidiary, provides us with facilities, equipment and financial services. In addition, they purify our proteins and transposase, as well as being collaborators.
University of Minnesota
The University of Minnesota provides us with the clinical leadership and facilities for our clinical trials in addition to exclusive licenses to some of our technology.
Our collaborative agreement with AngioGenetics, a Swedish company, gives us a unique capability in angiogenesis the formation of blood vessels which in turn may lead to valuable patents applicable to cancer and ischemia.